Back
Sarepta Therapeutics Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
SRPT
Sarepta Therapeutics
Last Price:
$54.38
Seasonality Move:
15.14%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.54 | Sell |
| 20-day SMA: | 78.39 | Sell |
| 50-day SMA: | 97.73 | Sell |
| 200-day SMA: | 122.38 | Sell |
| 8-day EMA: | 63.87 | Sell |
| 20-day EMA: | 75.73 | Sell |
| 50-day EMA: | 92.2 | Sell |
| 200-day EMA: | 113.44 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -11.96 | Sell |
| Relative Strength Index (14 RSI): | 19.8 | Sell |
| Chaikin Money Flow: | -4277485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.24 - 101.14) | Sell |
| Bollinger Bands (100): | (90.97 - 127.95) | Sell |
Sarepta Therapeutics Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 54.43 while SRPT 8-day simple moving average is 64.54, which is a Sell signal.
-
The stock price of SRPT is 54.43 while Sarepta Therapeutics 20-day SMA is 78.39, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 97.73 while SRPT share price is 54.43, making it a Sell technically.
-
SRPT stock price is 54.43 and Sarepta Therapeutics 200-day simple moving average is 122.38, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
46
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a SellThe current Sarepta Therapeutics [SRPT] share price is $54.43. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
5.3B
Price in USD:
54.43
Share Volume:
4.6M
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
54.26
Sell
46
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 54.43 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 54.43 while SRPT 8-day exponential moving average is 63.87, which is a Sell signal.
-
The stock price of SRPT is 54.43 while Sarepta Therapeutics 20-day EMA is 75.73, which makes it a Sell.
-
Sarepta Therapeutics 50-day exponential moving average is 92.20 while SRPT share price is 54.43, making it a Sell technically.
-
SRPT stock price is 54.43 and Sarepta Therapeutics 200-day simple moving average is 113.44, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $2.39 per share, a decrease next quarter of $0.51 per share, an increase this year of $5.17 per share, and an increase next year of $5.45 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is -11.96, suggesting Sarepta Therapeutics is a Sell
-
Sarepta Therapeutics Relative Strength Index (RSI) is 19.8, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (66.24 - 101.14), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (90.97 - 127.95), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.